ANVISA registration

LIAISON XL MUREX recHTLV-I/II

Registration 10339840483. ANTICORPO PARA VÍRUS DE T-LINFOTRÓPICO HUMANO 1 E 2 (HTLV1 E HTLV2)

Registration details

Registration number10339840483
Application number25351719507201738
Technical nameANTICORPO PARA VÍRUS DE T-LINFOTRÓPICO HUMANO 1 E 2 (HTLV1 E HTLV2)
Risk classIV
Published on30/04/2018
ValidityValid until 30/04/2028

Registration holder

Legal nameDIASORIN LTDA
CNPJ01.896.764/0001-70

Manufacturer

  • DIASORIN ITALIA S.P.A. ITÁLIA

Other registrations held by DIASORIN LTDAview all

LIAISON Tg

10339840125

LIAISON T3

10339840126

LIAISON CA 15-3

10339840127

LIAISON FT3

10339840128

LIAISON CA 19-9

10339840129

LIAISON CA-125 II

10339840130

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist